Kidney And Liver Cancer Drug Raises High Blood Pressure Risk
Jan 29th 2008Drug InformationCancer
Sorafenib, a new anti tumour (antineoplastic) drug marketed by Bayer under the brand Nexavar, and used to treat patients with advanced kidney or liver cancer, has been found to increase significantly the risk of developing high blood pressure.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
